DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its ...

DURHAM, N.C. and SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors ...

The final purchase price is in for Charney Companies and Tavros Capital’s latest site in Gowanus. Charney and Tavros bought the site at 175 Third Street from Aby Rosen’s RFR Realty for $164 ...